Symbol | YTM % | Wolumen | Cena % | Kupon % | Termin zapadalności | Kwota niezapłacona | Wartość nominalna | Min. kw. nominału | Emitent |
---|---|---|---|---|---|---|---|---|---|
6,63% | 2,68 M | 67,34% | 3,18% | 2050-07-09 | 2 B USD | 1 000,00 USD | 200 000,00 USD | Takeda Pharmaceutical Co., Ltd. | |
6,56% | 1,29 M | 66,06% | 3,38% | 2060-07-09 | 1 B USD | 1 000,00 USD | 200 000,00 USD | Takeda Pharmaceutical Co., Ltd. | |
6,13% | 2,82 M | 75,44% | 3,03% | 2040-07-09 | 1,5 B USD | 1 000,00 USD | 200 000,00 USD | Takeda Pharmaceutical Co., Ltd. | |
5,85% | 1,93 M | 99,37% | 5,80% | 2064-07-05 | 500 M USD | 1 000,00 USD | 200 000,00 USD | Takeda Pharmaceutical Co., Ltd. | |
5,66% | 10 M | 99,94% | 5,65% | 2054-07-05 | 600 M USD | 1 000,00 USD | 200 000,00 USD | Takeda Pharmaceutical Co., Ltd. | |
TTKPH4369980Baxalta Incorporated 5.25% 23-JUN-2045 | 5,62% | 61 K | 96,50% | 5,25% | 2045-06-23 | 500,41 M USD | 1 000,00 USD | 2 000,00 USD | Baxalta, Inc. |
5,46% | 3,2 M | 101,79% | 5,65% | 2044-07-05 | 800 M USD | 1 000,00 USD | 200 000,00 USD | Takeda Pharmaceutical Co., Ltd. | |
5,04% | 2,64 M | 87,89% | 2,05% | 2030-03-31 | 2,5 B USD | 1 000,00 USD | 200 000,00 USD | Takeda Pharmaceutical Co., Ltd. | |
5,04% | 200 K | 101,67% | 5,30% | 2034-07-05 | 1,1 B USD | 1 000,00 USD | 200 000,00 USD | Takeda Pharmaceutical Co., Ltd. | |
TTKPH4370840Baxalta Incorporated 4.0% 23-JUN-2025 | 4,74% | 12 K | 99,78% | 4,00% | 2025-06-23 | 800,17 M USD | 1 000,00 USD | 2 000,00 USD | Baxalta, Inc. |
4,60% | 1,03 M | 101,29% | 5,00% | 2028-11-26 | 1,73 B USD | 1 000,00 USD | 200 000,00 USD | Takeda Pharmaceutical Co., Ltd. | |
UUS82481LAD1SHIRE ACQUIST.I.IE 16/26 | 4,49% | 0 | 98,12% | 3,20% | 2026-09-23 | 1,5 B USD | 1 000,00 USD | 2 000,00 USD | Shire Acquisitions Investments Ireland DAC |
4,29% | 0 | 78,77% | 2,00% | 2040-07-09 | 1 B EUR | 1 000,00 EUR | 100 000,00 EUR | Takeda Pharmaceutical Co., Ltd. | |
3,39% | 0 | 88,16% | 1,38% | 2032-07-09 | 1 B EUR | 1 000,00 EUR | 100 000,00 EUR | Takeda Pharmaceutical Co., Ltd. | |
3,11% | 0 | 99,46% | 3,00% | 2030-11-21 | 1,5 B EUR | 1 000,00 EUR | 100 000,00 EUR | Takeda Pharmaceutical Co., Ltd. | |
2,99% | 0 | 92,34% | 1,00% | 2029-07-09 | 850 M EUR | 1 000,00 EUR | 100 000,00 EUR | Takeda Pharmaceutical Co., Ltd. | |
2,81% | 0 | 95,46% | 0,75% | 2027-07-09 | 750 M EUR | 1 000,00 EUR | 100 000,00 EUR | Takeda Pharmaceutical Co., Ltd. | |
2,71% | 0 | 116,57% | 5,00% | 2028-11-26 | 22,68 M USD | 1 000,00 USD | 200 000,00 USD | Takeda Pharmaceutical Co., Ltd. | |
2,71% | 0 | 99,25% | 2,25% | 2026-11-21 | 1,5 B EUR | 1 000,00 EUR | 100 000,00 EUR | Takeda Pharmaceutical Co., Ltd. | |
SSHPG4260178Baxalta Incorporated 4.0% 23-JUN-2025 | — | — | — | 4,00% | 2025-06-23 | 303 K USD | 1 000,00 USD | 2 000,00 USD | Baxalta, Inc. |
— | — | — | 5,00% | 2028-11-26 | 22,68 M USD | 1 000,00 USD | 200 000,00 USD | Takeda Pharmaceutical Co., Ltd. |